Testing the Effect of Taking Ruxolitinib and CPX-351 in Combination for the Treatment of Advanced Phase Myeloproliferative Neoplasms
Ohio State University Comprehensive Cancer Center
Ohio State University Comprehensive Cancer Center
Eastern Cooperative Oncology Group
National Cancer Institute (NCI)
Pfizer
Hospital Israelita Albert Einstein
Stichting Hemato-Oncologie voor Volwassenen Nederland
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Children's Oncology Group
National Cancer Institute (NCI)